The association of intratumoral germinal centers with early-stage non-small cell lung cancer

Journal of Thoracic Oncology

Volumn 6, Issue 10, 2011, Pages 1687-1690

  Gottlin, Elizabeth B ^a   Bentley, Rex C ^b   Campa, Michael J ^a   Pisetsky, David S ^c   Herndon, James E ^a   Patz, Edward F ^a  

^a DUKE UNIVERSITY   (United States)

^b Department of Pathology ^*  (United States)

^c DURHAM VA MEDICAL CENTER   (United States)

Author keywords

Germinal centers; Humoral immunity; Metastasis; Non small cell lung cancer

Indexed keywords

COMPLEMENT COMPONENT C3D RECEPTOR; PROTEIN BCL 6;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; FEMALE; FOLLOW UP; GERMINAL CENTER; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL;

EID: 80052969850     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182217bec     Document Type: Article

References (18)

1. Groome PA, Bolejack V, Crowley JJ, et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:694-705. (Pubitemid 47357521)
2. Christensen JD, Colby TV, Patz EF Jr. Correlation of [18F]-2-fluorodeoxy- D-glucose positron emission tomography standard uptake values with the cellular composition of stage I nonsmall cell lung cancer. Cancer 2010;116:4095-4102.
3. Mantovani A, Garlanda C, Allavena P. Molecular pathways and targets in cancer-related inflammation. Ann Med 2010;42:161-170.
4. DeNardo DG, Andreu P, Coussens LM. Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity. Cancer Metastasis Rev 2010;29:309-316.
5. MacLennan IC. Germinal centers. Annu Rev Immunol 1994;12:117-139. (Pubitemid 24140411)
6. Coronella JA, Spier C, Welch M, et al. Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast. J Immunol 2002;169:1829-1836. (Pubitemid 34857644)
7. Kotlan B, Simsa P, Foldi J, et al. Immunoglobulin repertoire of B lymphocytes infiltrating breast medullary carcinoma. Hum Antibodies 2003;12:113-121. (Pubitemid 38657147)
8. Kotlan B, Simsa P, Teillaud JL, et al. Novel ganglioside antigen identified by B cells in human medullary breast carcinomas: the proof of principle concerning the tumor-infiltrating B lymphocytes. J Immunol 2005;175:2278-2285. (Pubitemid 41113835)
9. Nzula S, Going JJ, Stott DI. Antigen-driven clonal proliferation, somatic hypermutation, and selection of B lymphocytes infiltrating human ductal breast carcinomas. Cancer Res 2003;63:3275-3280. (Pubitemid 36735883)
10. Willis SN, Mallozzi SS, Rodig SJ, et al. The microenvironment of germ cell tumors harbors a prominent antigen-driven humoral response. J Immunol 2009;182:3310-3317.
11. Dieu-Nosjean MC, Antoine M, Danel C, et al. Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 2008;26:4410-4417.
12. Pagès F, Galon J, Dieu-Nosjean MC, et al. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 2010;29:1093-1102.
13. Cattoretti G, Chang CC, Cechova K, et al. BCL-6 protein is expressed in germinal-center B cells. Blood 1995;86:45-53.
14. Phan TG, Gardam S, Basten A, et al. Altered migration, recruitment, and somatic hypermutation in the early response of marginal zone B cells to T cell-dependent antigen. J Immunol 2005;174:4567-4578.
15. Roozendaal R, Carroll MC. Complement receptors CD21 and CD35 in humoral immunity. Immunol Rev 2007;219:157-166. (Pubitemid 47390008)
16. Rossbacher J, Haberman AM, Neschen S, et al. Antibody-independent B cell-intrinsic and-extrinsic roles for CD21/35. Eur J Immunol 2006;36: 2384-2393. (Pubitemid 44420595)
17. Hara I, Takechi Y, Houghton AN. Implicating a role for immune recognition of self in tumor rejection: passive immunization against the brown locus protein. J Exp Med 1995;182:1609-1614.
18. Amornsiripanitch N, Hong S, Campa MJ, et al. Complement factor H autoantibodies are associated with early stage NSCLC. Clin Cancer Res 2010;16:3226-3231.